InfuSystem Holdings Inc (INFU) CEO Richard Dilorio Acquires 3,900 Shares of Stock

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) CEO Richard Dilorio purchased 3,900 shares of the firm’s stock in a transaction dated Monday, March 11th. The shares were bought at an average price of $4.22 per share, with a total value of $16,458.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Shares of NYSEAMERICAN INFU traded down $0.02 during trading hours on Thursday, hitting $4.22. 309 shares of the company’s stock were exchanged, compared to its average volume of 22,965. InfuSystem Holdings Inc has a 1-year low of $2.25 and a 1-year high of $4.30.

InfuSystem (NYSEAMERICAN:INFU) last posted its quarterly earnings data on Thursday, March 7th. The medical instruments supplier reported ($0.01) earnings per share for the quarter. The company had revenue of $17.56 million during the quarter.



Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP raised its holdings in InfuSystem by 7.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 228,305 shares of the medical instruments supplier’s stock valued at $785,000 after acquiring an additional 16,065 shares in the last quarter. Renaissance Technologies LLC raised its holdings in shares of InfuSystem by 13.2% in the 3rd quarter. Renaissance Technologies LLC now owns 301,096 shares of the medical instruments supplier’s stock worth $979,000 after buying an additional 34,996 shares in the last quarter. Gamco Investors INC. ET AL raised its holdings in shares of InfuSystem by 142.1% in the 3rd quarter. Gamco Investors INC. ET AL now owns 84,998 shares of the medical instruments supplier’s stock worth $276,000 after buying an additional 49,888 shares in the last quarter. Gabelli Funds LLC raised its holdings in shares of InfuSystem by 23.2% in the 3rd quarter. Gabelli Funds LLC now owns 345,000 shares of the medical instruments supplier’s stock worth $1,121,000 after buying an additional 65,000 shares in the last quarter. Finally, Price Wealth Management Inc. acquired a new position in shares of InfuSystem in the 4th quarter worth approximately $688,000.

COPYRIGHT VIOLATION NOTICE: “InfuSystem Holdings Inc (INFU) CEO Richard Dilorio Acquires 3,900 Shares of Stock” was originally published by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://dakotafinancialnews.com/2019/03/14/infusystem-holdings-inc-infu-ceo-richard-dilorio-acquires-3900-shares-of-stock.html.

InfuSystem Company Profile

InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Further Reading: What is Cost of Capital?

Insider Buying and Selling by Quarter for InfuSystem (NYSEAMERICAN:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.